Division of Rheumatology Leads Partnership to Study Pathways in Autoimmune and Immune-Mediated Diseases (AIM)

/PRNewswire/ -- NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune...

Related Keywords

California ,United States ,Michigan ,San Francisco ,Joseu Scher ,Ryan Dziuba ,Steven Abramson ,Caroline Shiboski ,Jill Buyon ,Peterm Izmirly ,Medicines Partnership Autoimmune ,Johns Hopkins University ,University Of California ,Lupus Research ,Langone Health ,Teach Microbiome Technology ,Ohio State University ,University Of Texas South ,University Of Michigan ,Team For Accelerating Medicines Partnership ,University Of Rochester ,Langone Division Of Rheumatology ,Clemente Lab ,Department Of Medicine ,Division Of Rheumatology ,Analytic Center Hub ,Lupus Omics Cutaneous Kidney Investigation Team ,Albert Einstein College Of Medicine ,National Institutes Of Health ,Drug Administration ,Icahn School Of Medicine At Mount Sinai ,University Of Pennsylvania ,National Institutes ,Accelerating Medicines Partnership Autoimmune ,Immune Mediated Diseases ,Sir Deryck ,Lady Va Maughan Professor ,Steere Abramson Associate Professor ,Albert Einstein College ,Texas South ,Microbiome Technology ,Icahn School ,Psoriatic Skin ,Systems Biology ,Accelerating Medicines Partnership ,Nyu Langone Health ,